Open AccessEfficacy and Safety of Fluticasone Furoate and Oxymetazoline Nasal Spray: A Novel First Fixed Dose Combination for the Management of Allergic Rhinitis with Nasal Congestion
Author(s) -
Rahul Kumar,
Manish Kumar Jain,
Jitendra Singh Kushwaha,
Santosh Patil,
Vasanti Patil,
Soumya Ghatak,
Jayesh Sanmukhani,
Ravindra Mittal
Publication year - 2022
Publication title -
journal of asthma and allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.162
H-Index - 30
ISSN - 1178-6965
DOI - 10.2147/jaa.s357288
Subject(s) - medicine , fluticasone propionate , nasal congestion , oxymetazoline , fluticasone , nasal spray , nasal administration , anesthesia , nostril , randomized controlled trial , corticosteroid , nose , nasal decongestant , surgery , pharmacology , adrenergic receptor , receptor
To compare the efficacy and safety of a fixed dose combination of Fluticasone Furoate and Oxymetazoline Hydrochloride Nasal Spray 27.5/50 mcg (FDC) with Fluticasone Furoate Nasal Spray 27.5 mcg (Fluticasone) in the management of allergic rhinitis.